Kaplan-Meier survival analysis of these 64 colon cancer patients displayed that colon cancer patients with lower B3GALT5-AS1 expression had worse survival than those with higher B3GALT5-AS1 expression (Fig. 1E). Here, B3GALT5 is linked to malignant colon neoplasm.